Carfilzomib Is Safe in Elderly Patients with Multiple Myeloma but Thrombotic Microangiopathy Is Underestimated in Clinical Practice

被引：0
|
作者：
Terao, Toshiki [1 ]
Tsushima, Takafumi [1 ]
Miura, Daisuke [2 ]
Ikeda, Daisuke [3 ]
Fukumoto, Ami [3 ]
Kuzume, Ayumi [1 ]
Tabata, Rikako [1 ]
Narita, Kentaro [2 ]
Takeuchi, Masami [1 ]
Matsue, Kosei [4 ]
机构：
[1] Kameda Med Ctr, Div Hematol Oncol, Kamogawa, Japan
[2] Kameda Med Ctr, Div Hematol Oncol, Dept Med, Kamogawa, Japan
[3] Kameda Med Ctr, Kamogawashi, Japan
[4] Kameda Gen Hosp, Div Hematol Oncol, Kamogawa, Japan
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-146460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3798
引用
收藏
页码：3798 / +
页数：5
相关论文
共 50 条
  • [41] Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
    De Novellis, Danilo
    Derudas, Daniele
    Vincelli, Donatella
    Fontana, Raffaele
    Della Pepa, Roberta
    Palmieri, Salvatore
    Accardi, Fabrizio
    Rotondo, Francesco
    Morelli, Emanuela
    Gigliotta, Emilia
    Roccotelli, Daniela
    Marano, Luana
    Barone, Maria Lucia
    Cetani, Giusy
    Esposito, Daniela
    Lazzaro, Antonio
    Delle Cave, Giuseppe
    Serio, Bianca
    Morini, Denise
    Porrazzo, Marika
    Urciuoli, Eleonora
    Masucci, Chiara
    Fanelli, Fulvia
    Rizzo, Michela
    Arcamone, Manuela
    Trastulli, Fabio
    Rocco, Stefano
    Leone, Aldo
    Bianco, Rosario
    Salvatore, Flavia
    Idato, Aurora
    Sicari, Maria
    Tosi, Patrizia
    Rascato, Maria Gabriella
    Di Perna, Maria
    Falcone, Antonietta Pia
    Morello, Lucia
    Carlisi, Melania
    Svanera, Gino
    Annunziata, Mario
    Frigeri, Ferdinando
    Califano, Catello
    Carella, Angelo Michele
    Marcacci, Gianpaolo
    Pane, Fabrizio
    Risitano, Antonio Maria
    Giudice, Valentina
    Botta, Ciro
    Selleri, Carmine
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (01) : 105 - 114
  • [42] Does the choice of thrombotic prophylactic drug depend on the known risk factors of patients with multiple myeloma in clinical practice?
    Chalayer, E.
    Chapelle, C.
    Leleu, X.
    Elalamy, I.
    Laporte, S.
    Tardy, B.
    THROMBOSIS RESEARCH, 2016, 143 : 101 - 102
  • [43] THE EUROPEAN MYELOMA NETWORK EMN09 STUDY: CARFILZOMIB, BENDAMUSTINE, AND DEXAMETHASONE IS EFFICIENT AND SAFE IN PATIENTS WITH ADVANCED MULTIPLE MYELOMA
    Gramatzki, M.
    Guenther, A.
    Offidani, M.
    Engelhardt, M.
    Gentili, S.
    Montefusco, V.
    Patriarca, F.
    Angelucci, E.
    Schub, N.
    Astolfi, M.
    Poenisch, W.
    Einsele, H.
    Sonneveld, P.
    Corradini, P.
    Palumbo, A.
    Gay, F.
    HAEMATOLOGICA, 2017, 102 : 113 - 113
  • [44] Cardiac and renal complications of carfilzomib in patients with multiple myeloma
    Dimopoulos, Meletios A.
    Roussou, Maria
    Gavriatopoulou, Maria
    Psimenou, Erasmia
    Ziogas, Dimitrios
    Eleutherakis-Papaiakovou, Evangelos
    Fotiou, Despina
    Migkou, Magdalini
    Kanellias, Nikolaos
    Panagiotidis, Ioannis
    Ntalianis, Argyrios
    Papadopoulou, Elektra
    Stamatelopoulos, Kimon
    Manios, Efstathios
    Pamboukas, Constantinos
    Kontogiannis, Sofoklis
    Terpos, Evangelos
    Kastritis, Efstathios
    BLOOD ADVANCES, 2017, 1 (07) : 449 - 454
  • [45] Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myeloma
    Stewart, A. Keith
    FUTURE ONCOLOGY, 2015, 11 (15) : 2121 - 2136
  • [46] WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (WKCYD) FOLLOWED BY MAINTENANCE WITH WEEKLY CARFILZOMIB (WK) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
    Bringhen, S.
    De Paoli, L.
    Larocca, A.
    Ballanti, S.
    Gentilini, F.
    Liberati, A. M.
    Passera, R.
    Bernardini, A.
    Esma, F.
    Galieni, P.
    Offidani, M.
    Corradini, P.
    Gaidano, G.
    Boccadoro, M.
    Sonneveld, P.
    Palumbo, A.
    HAEMATOLOGICA, 2016, 101 : 2 - 2
  • [47] Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
    Gupta, Vikas A.
    Nooka, Ajay K.
    Lonial, Sagar
    Boise, Lawrence H.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2013, 3 : 41 - 51
  • [48] Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma
    Qazilbash, M. H.
    Saliba, R. M.
    Hosing, C.
    Mendoza, F.
    Qureshi, S. R.
    Weber, D. M.
    Wang, M.
    Flosser, T.
    Couriel, D. R.
    De Lima, M.
    Kebriaei, P.
    Popat, U.
    Alousi, A. M.
    Champlin, R. E.
    Giralt, S. A.
    BONE MARROW TRANSPLANTATION, 2007, 39 (05) : 279 - 283
  • [49] Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma
    M H Qazilbash
    R M Saliba
    C Hosing
    F Mendoza
    S R Qureshi
    D M Weber
    M Wang
    T Flosser
    D R Couriel
    M De Lima
    P Kebriaei
    U Popat
    A M Alousi
    R E Champlin
    S A Giralt
    Bone Marrow Transplantation, 2007, 39 : 279 - 283
  • [50] AUTOLOGOUS STEM CELL TRANSPLANTATION IS SAFE IN SELECTED ELDERLY MULTIPLE MYELOMA PATIENTS
    Staderini, M.
    Antonioli, E.
    Nozzoli, C.
    Buda, G.
    Boncompagni, R.
    Petrini, M.
    Saccardi, R.
    Bosi, A.
    HAEMATOLOGICA, 2019, 104 : 69 - 69
12345